These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10943039)

  • 1. [Comparison of cathepsin-B-like activity and CA 125 assays use in ovarian cancer diagnosis].
    Warwas M; Gerber J; Haczyńska H; Lukasik-Lemańska K
    Ginekol Pol; 2000 May; 71(5):400-5. PubMed ID: 10943039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B-like activity as a serum tumour marker in ovarian carcinoma.
    Warwas M; Haczyńska H; Gerber J; Nowak M
    Eur J Clin Chem Clin Biochem; 1997 Apr; 35(4):301-4. PubMed ID: 9166974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictive value of CA 125 in detection of ovarian cancer in pre- and postmenopausal patients].
    Grzybowski W; Beta J; Fritz A; Durczyński A; Bidziński M; Grabiec M; Jakimiuk AJ
    Ginekol Pol; 2010 Jul; 81(7):511-5. PubMed ID: 20825052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker].
    Zeimet AG; Guadagni F; Marth C; Amato T; Müller-Holzner E; Huter O; Daxenbichler G; Dapunt O
    Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):195-9. PubMed ID: 7789707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of the morphological ultrasound score system and the serum concentration of CA 125 in the diagnosis of malignant ovarian cancer].
    Brazert J; Pietryga M; Szabłoński W; Persona-Sliwińska A; Biczysko R
    Ginekol Pol; 2003 Dec; 74(12):1542-8. PubMed ID: 15029747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer.
    Peters-Engl C; Medl M; Ogris E; Leodolter S
    Anticancer Res; 1995; 15(6B):2727-30. PubMed ID: 8669854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors.
    Lenhard MS; Nehring S; Nagel D; Mayr D; Kirschenhofer A; Hertlein L; Friese K; Stieber P; Burges A
    Clin Chem Lab Med; 2009; 47(5):537-42. PubMed ID: 19317653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dependence of serous activity of cathepsin B on histological types of ovarian carcinomas].
    Haczyńska H; Gerber J; Warwas M; Andrzejewski L
    Ginekol Pol; 1998 Apr; 69(4):191-5. PubMed ID: 9640864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer.
    Downs LS; Lima PH; Bliss RL; Blomquist CH
    J Soc Gynecol Investig; 2005 Oct; 12(7):539-44. PubMed ID: 16202931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activities and subcellular localization of cathepsin B and cysteine proteinase inhibitors in human ovarian carcinoma.
    Haczyńksa H; Gerber J; Osada J; Warwas M
    Acta Biochim Pol; 1997; 44(1):113-20. PubMed ID: 9241362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
    Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer.
    Kolwijck E; Span PN; Thomas CM; Bulten J; Sweep FC; Massuger LF
    Oncol Rep; 2010 Feb; 23(2):579-84. PubMed ID: 20043124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.
    Nishikawa H; Ozaki Y; Nakanishi T; Blomgren K; Tada T; Arakawa A; Suzumori K
    Gynecol Oncol; 2004 Mar; 92(3):881-6. PubMed ID: 14984956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level.
    Fularz M; Adamiak P; Czepczyński R; Jarząbek-Bielecka G; Rewers A; Kędzia W; Ruchała M
    Nuklearmedizin; 2015; 54(4):158-62. PubMed ID: 26076719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
    Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
    An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistological analysis of stress-induced phosphoprotein 1 in ovarian cancer patients with low serum cancer antigen 125 levels.
    Chao A; Lee LY; Hsueh C; Lin CY; Tsai CL; Chao AS; Lin CT; Chou HH; Chang TC; Wang TH
    Taiwan J Obstet Gynecol; 2013 Jun; 52(2):185-91. PubMed ID: 23915849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.